Literature DB >> 21799585

Informing sequential clinical decision-making through reinforcement learning: an empirical study.

Susan M Shortreed1, Eric Laber, Daniel J Lizotte, T Scott Stroup, Joelle Pineau, Susan A Murphy.   

Abstract

This paper highlights the role that reinforcement learning can play in the optimization of treatment policies for chronic illnesses. Before applying any off-the-shelf reinforcement learning methods in this setting, we must first tackle a number of challenges. We outline some of these challenges and present methods for overcoming them. First, we describe a multiple imputation approach to overcome the problem of missing data. Second, we discuss the use of function approximation in the context of a highly variable observation set. Finally, we discuss approaches to summarizing the evidence in the data for recommending a particular action and quantifying the uncertainty around the Q-function of the recommended policy. We present the results of applying these methods to real clinical trial data of patients with schizophrenia.

Entities:  

Year:  2011        PMID: 21799585      PMCID: PMC3143507          DOI: 10.1007/s10994-010-5229-0

Source DB:  PubMed          Journal:  Mach Learn        ISSN: 0885-6125            Impact factor:   2.940


  20 in total

1.  Schizophrenia trials: past, present and future.

Authors:  Clive E Adams
Journal:  Epidemiol Psichiatr Soc       Date:  2002 Jul-Sep

2.  An experimental design for the development of adaptive treatment strategies.

Authors:  S A Murphy
Journal:  Stat Med       Date:  2005-05-30       Impact factor: 2.373

3.  Covariate-adjusted adaptive randomization in a sarcoma trial with multi-stage treatments.

Authors:  Peter F Thall; J Kyle Wathen
Journal:  Stat Med       Date:  2005-07-15       Impact factor: 2.373

4.  Multiple imputation of discrete and continuous data by fully conditional specification.

Authors:  Stef van Buuren
Journal:  Stat Methods Med Res       Date:  2007-06       Impact factor: 3.021

5.  Reinforcement learning design for cancer clinical trials.

Authors:  Yufan Zhao; Michael R Kosorok; Donglin Zeng
Journal:  Stat Med       Date:  2009-11-20       Impact factor: 2.373

6.  Placebo-free designs for evaluating new mental health treatments: the use of adaptive treatment strategies.

Authors:  Ree Dawson; Philip W Lavori
Journal:  Stat Med       Date:  2004-11-15       Impact factor: 2.373

7.  Methodological challenges in constructing effective treatment sequences for chronic psychiatric disorders.

Authors:  Susan A Murphy; David W Oslin; A John Rush; Ji Zhu
Journal:  Neuropsychopharmacology       Date:  2006-11-08       Impact factor: 7.853

8.  Sequenced treatment alternatives to relieve depression (STAR*D): rationale and design.

Authors:  A John Rush; Maurizio Fava; Stephen R Wisniewski; Philip W Lavori; Madhukar H Trivedi; Harold A Sackeim; Michael E Thase; Andrew A Nierenberg; Frederic M Quitkin; T Michael Kashner; David J Kupfer; Jerrold F Rosenbaum; Jonathan Alpert; Jonathan W Stewart; Patrick J McGrath; Melanie M Biggs; Kathy Shores-Wilson; Barry D Lebowitz; Louise Ritz; George Niederehe
Journal:  Control Clin Trials       Date:  2004-02

9.  Bayesian clinical trials at the University of Texas M. D. Anderson Cancer Center.

Authors:  Swati Biswas; Diane D Liu; J Jack Lee; Donald A Berry
Journal:  Clin Trials       Date:  2009-06       Impact factor: 2.486

10.  Assessing clinical and functional outcomes in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial.

Authors:  Marvin S Swartz; Diana O Perkins; T Scott Stroup; Joseph P McEvoy; Jennifer M Nieri; David C Haak
Journal:  Schizophr Bull       Date:  2003       Impact factor: 9.306

View more
  33 in total

1.  Set-valued dynamic treatment regimes for competing outcomes.

Authors:  Eric B Laber; Daniel J Lizotte; Bradley Ferguson
Journal:  Biometrics       Date:  2014-01-08       Impact factor: 2.571

2.  Q-learning residual analysis: application to the effectiveness of sequences of antipsychotic medications for patients with schizophrenia.

Authors:  Ashkan Ertefaie; Susan Shortreed; Bibhas Chakraborty
Journal:  Stat Med       Date:  2016-01-10       Impact factor: 2.373

3.  Q- and A-learning Methods for Estimating Optimal Dynamic Treatment Regimes.

Authors:  Phillip J Schulte; Anastasios A Tsiatis; Eric B Laber; Marie Davidian
Journal:  Stat Sci       Date:  2014-11       Impact factor: 2.901

4.  Multi-Objective Markov Decision Processes for Data-Driven Decision Support.

Authors:  Daniel J Lizotte; Eric B Laber
Journal:  J Mach Learn Res       Date:  2016-12-01       Impact factor: 3.654

5.  Precision Medicine.

Authors:  Michael R Kosorok; Eric B Laber
Journal:  Annu Rev Stat Appl       Date:  2019-03       Impact factor: 5.810

6.  Linear Fitted-Q Iteration with Multiple Reward Functions.

Authors:  Daniel J Lizotte; Michael Bowling; Susan A Murphy
Journal:  J Mach Learn Res       Date:  2012-11       Impact factor: 3.654

7.  Initial management strategies for follicular lymphoma.

Authors:  Qiushi Chen; Turgay Ayer; Loretta J Nastoupil; Miray Seward; Hongzheng Zhang; Rajni Sinha; Christopher R Flowers
Journal:  Int J Hematol Oncol       Date:  2012-10

8.  Q-learning for estimating optimal dynamic treatment rules from observational data.

Authors:  Erica E M Moodie; Bibhas Chakraborty; Michael S Kramer
Journal:  Can J Stat       Date:  2012-11-07       Impact factor: 0.875

9.  Mobile health technology evaluation: the mHealth evidence workshop.

Authors:  Santosh Kumar; Wendy J Nilsen; Amy Abernethy; Audie Atienza; Kevin Patrick; Misha Pavel; William T Riley; Albert Shar; Bonnie Spring; Donna Spruijt-Metz; Donald Hedeker; Vasant Honavar; Richard Kravitz; R Craig Lefebvre; David C Mohr; Susan A Murphy; Charlene Quinn; Vladimir Shusterman; Dallas Swendeman
Journal:  Am J Prev Med       Date:  2013-08       Impact factor: 5.043

10.  Estimation of optimal dynamic treatment regimes.

Authors:  Ying-Qi Zhao; Eric B Laber
Journal:  Clin Trials       Date:  2014-05-28       Impact factor: 2.486

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.